Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Pavlidis

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Diagnostics (Basel, Switzerland)|May 22, 2019
PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca"Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, et al.
Psycho-Oncology|January 30, 2013
Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary siteThomas Hyphantis, Ilias Papadimitriou, Dimitrios Petrakis, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2021
Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of OncologyNicholas Pavlidis, Fedro A Peccatori, Matti Aapro, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 22, 2021
The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian RegionsNicholas Pavlidis, Alisher Kahharov, Fedro A Peccatori, et al.
Journal of Advanced Research|August 11, 2015
Development of a low grade lymphoma in the mastoid bone in a patient with atypical Cogan's syndrome: A case reportChris Kalogeropoulos, Dimitrios Karachalios, George Pentheroudakis, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2020
The role of site-specific therapy for cancers of unknown of primary: A meta-analysisElie Rassy, Ziad Bakouny, Toni K Choueiri, et al.
Drugs in R&D|March 28, 2020
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Charlotte Abson, Michele Moschetta, et al.
American Journal of Clinical Oncology|December 15, 2004
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyAristotle Bamias, Konstantinos Syrigos, George Fountzilas, et al.
Cancers|August 26, 2022
BRCA Mutations in Ovarian and Prostate Cancer: Bench to BedsideStergios Boussios, Elie Rassy, Michele Moschetta, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphomaTheofanis Economopoulos, George Fountzilas, Nicholas Pavlidis, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Diagnostics (Basel, Switzerland)|May 22, 2019
PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca"Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, et al.
Psycho-Oncology|January 30, 2013
Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary siteThomas Hyphantis, Ilias Papadimitriou, Dimitrios Petrakis, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2021
Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of OncologyNicholas Pavlidis, Fedro A Peccatori, Matti Aapro, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 22, 2021
The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian RegionsNicholas Pavlidis, Alisher Kahharov, Fedro A Peccatori, et al.
Journal of Advanced Research|August 11, 2015
Development of a low grade lymphoma in the mastoid bone in a patient with atypical Cogan's syndrome: A case reportChris Kalogeropoulos, Dimitrios Karachalios, George Pentheroudakis, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2020
The role of site-specific therapy for cancers of unknown of primary: A meta-analysisElie Rassy, Ziad Bakouny, Toni K Choueiri, et al.
Drugs in R&D|March 28, 2020
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Charlotte Abson, Michele Moschetta, et al.
American Journal of Clinical Oncology|December 15, 2004
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyAristotle Bamias, Konstantinos Syrigos, George Fountzilas, et al.
Cancers|August 26, 2022
BRCA Mutations in Ovarian and Prostate Cancer: Bench to BedsideStergios Boussios, Elie Rassy, Michele Moschetta, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphomaTheofanis Economopoulos, George Fountzilas, Nicholas Pavlidis, et al.
Pageof 18